12 Aug, 11:39 - Indian

Nifty Midcap 100 56412.7 (-0.12)

Nifty 50 24561 (-0.10)

Nifty Pharma 21688 (0.39)

Nifty Smallcap 100 17513.7 (0.13)

Nifty IT 34800.95 (0.74)

Nifty Bank 55239.95 (-0.49)

SENSEX 80483.01 (-0.15)

Nifty Next 50 66324.7 (0.06)

12 Aug, 11:39 - Global

NIKKEI 225 42742.03 (2.20)

HANG SENG 24902.04 (-0.02)

S&P 6412.75 (0.02)

LOGIN HERE

companylogoHindustan Bio Sciences Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 532041 | NSE Symbol : | ISIN : INE597C01021 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
19-Jul-2025 31-Jul-2025 Quarterly Results Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve the following: 1. Un-audited financial results of the company for the first quarter ended on 30-06-2025 2 Any other matter with the permission of Chair The board of Directors in its meeting held on Thursday, July 31, 2025 approved the Un-audited Standalone Financial Results of the Company for the First Quarter ended on June 30, 2025. (As per BSE Announcement Dated on 31/07/2025)
19-May-2025 30-May-2025 Accounts Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the following: 1. Audited financial results and statements of the company for the quarter and year ended 31-03-2025. 2 Audit report for the year ended 31.03.2025. 3 Appointment of Secretarial Auditor for a period of 5 years from Financial Year 2025-26 to 2029-30. 4. Appointment of internal auditor 5 Any other matter with the permission of Chair. The Board of Directors of the company in its meeting held today i.e., on May 30, 2025 has: approved the Audited Standalone Financial Results of the company for the fourth quarter and the financial year ended on 31st March 2025 and the Audited Standalone Financial Statement for the financial year ended on 31st March 2025 along with Audit Report. approved the re-appointment of Mr. G. B. K. Viswanadham as Internal Auditor of the Company for the FY 2025-26. recommended the appointment of Mr. VBSS Prasad, Practicing Company Secretary as the Secretarial Auditor of the Company for a period of 5 consecutive years form FY 2025-2026 to FY 2029-30 for the approval of the shareholders at the ensuing Annual General Meeting The board in its meeting today i.e., on May 30, 2025 has recommended the appointment of Mr. VBSS Prasad, Practicing Company Secretary as the secretarial auditor of the company for a period of 5 consecutive years from FY 2025-26 and FY 2029-30, subject to the approval of shareholders. (As per BSE Announcement Dated on 30/05/2025)
15-Apr-2025 23-Apr-2025 Change in Other Executives Inter alia, to consider and approve the appointment of Company Secretary and Compliance Officer of the Company. This is to inform the Exchange that in meeting of the Board of Directors of M/s. HINDUSTAN BIO SCIENCES LIMITED held on Wednesday, the 23' day of April, 2025, the board approved the appointment of Mr. Devanshu Ravinder Dange as company secretary and compliance officer. This is to inform the exchange that in the meeting of board of directors held on Wednesday, 23rd April,2025, the board approved the appointment of Mr. Devanshu Ravinder Dange as Company secretary and compliance officer of the Company. Further, the details as per SEBI Circular dated July 13,2023 are mentioned in Annexure-I of the document. This is to inform the exchange that in the meeting of Board of Directors held on Wednesday, April 23, 2025, the Board approved the appointment of Mr. Devanshu Ravinder Dange as company secretary and compliance officer of the Company. (As Per BSE Announcement Dated on 23.04.2025)
20-Jan-2025 30-Jan-2025 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 ,inter alia, to consider and approve Intimation of Board Meeting Outcome of Board Meeting (As per BSE Announcement Dated on 30/01/2025)
17-Oct-2024 30-Oct-2024 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve Intimation of Board Meeting Outcome of Board Meeting (As per BSE Announcement Dated on 30/10/2024)
22-Jul-2024 31-Jul-2024 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2024 inter alia to consider and approve Intimation of Board Meeting Outcome of Board Meeting (As Per BSE Announcement dated on 31.07.2024)
10-May-2024 25-May-2024 Accounts HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Intimation of Board Meeting to be held on 25-05-2024 Outcome of Board Meeting held on 25-05-2024 (As Per BSE Announcement Dated on 25.05.2024)
12-Jan-2024 31-Jan-2024 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve Intimation of Board Meeting to be held on 31-01-2024 Board Meeting held on 31-01-2024 (As Per BSE Announcement Dated on 31/01/2024)
23-Nov-2023 04-Dec-2023 EGM HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/12/2023 inter alia to consider and approve Intimation of Board Meeting for considering the notice of EGM intended for regularization of additional directors and approval of appointment of CFO of the company HINDUSTAN BIO SCIENCES LIMITED has informed BSE about Board Meeting to be held on 04 Dec 2023 to consider Other business. Outcome of board meeting held on 04-12-2023 (As per BSE Announcement Dated on 04/12/2023) Board approved:- 1 The board of directors approved the notice of Extra Ordinary General Meeting of the members of the company to be held on 29' December, 2023 for the purpose of regularization of additional directors appointed by the Board of Directors of the Company on 31-10-2023 and also approving the appointment of CFO of the company. 2 The board appointed Mr. VBSS Prasad, Practicing Company Secretary as the Scrutinizer to the EGM to be held on 29' December, 2023. (As Per BSE Bulletin Dated on 04.12.2023)
19-Oct-2023 31-Oct-2023 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 inter alia to consider and approve Board Meeting Intimation Outcome of board meeting (As Per BSE Announcement Dated on 31/10/2023)
19-Jul-2023 31-Jul-2023 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2023 inter alia to consider and approve Intimation of Board Meeting To held On 31st July 2023 HINDUSTAN BIO SCIENCS LIMITED has informed BSE about Board Meeting to be held on 31 Jul 2023 to consider financial statements for the period ended June 2023. Financial results / Other business. Outcome of the board meeting (As per BSE Announcement Dated on 31/07/2023)
17-May-2023 30-May-2023 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Intimation of Board Meeting to held on 30th May 2023
10-Mar-2023 10-Mar-2023 Others outcome of board meeting
13-Feb-2023 13-Feb-2023 Reduction in Capital Outcome of Board Meeting held on 13.02.2023
21-Jan-2023 31-Jan-2023 Quarterly Results HINDUSTAN BIO SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve Un audited results for the quarter ended 31-12-2022 Outcome of Board Meeting held on 31-01-2023 (As Per BSE Announcement Dated on 31.01.2023)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +